Answers are grounded in this paper and cite their sources.
Prospective trial assesses the impact of SMILE on myopia progression and refractive outcomes in young adults, suggesting effective correction.
This study aimed to evaluate the effect of small-incision lenticule extraction (SMILE/KLEx) on axial length (AXL) progression and refractive stability in young adults with moderate to high myopia and documented preoperative progression. This prospective study included 100 eyes of 50 patients aged 18-21 years who underwent SMILE/KLEx. AXL, spherical equivalent (SE), corneal curvature, and central corneal thickness (CCT) were measured 1 year pre-baseline (T - 1), at baseline (T0), and postoperatively at 6 months (T1), 1 year (T2), and 3 years (T3). Agreement between estimated and observed AXL elongation was assessed using Bland-Altman analysis, and generalized estimating equation (GEE) models were used to account for inter-eye correlations and evaluate changes from baseline. Median AXL showed limited progression throughout follow-up (26.05 mm at T0, 26.14 mm at T2, 26.26 mm at T3), SE improved from - 6.00 D to - 0.25 D, and corneal parameters showed early postoperative changes followed by long-term stability. Visual outcomes were satisfactory, with no significant intraoperative or postoperative complications. In conclusion, SMILE/KLEx provided effective refractive correction in this cohort of young adults with documented preoperative myopic progression. Over 3 years, axial length showed no statistically significant progression at the group level, although individual-level elongation was heterogeneous and remained within the expected physiological range for young adults.
No takes yet. Share an insight, caveat, or question.
Mastropasqua et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: